Bristol-Myers Squibb Other Region — Total Revenues increased by 7.4% to $290.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $271.00M to $290.00M. Over 3 years (FY 2021 to FY 2024), Other Region — Total Revenues shows an upward trend with a 5.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful market penetration or growth in secondary geographic regions, while a decrease may indicate a strategic withdrawal or declining demand in those specific areas.
This metric represents the aggregate net sales generated from geographic regions or business activities not explicitly c...
Peers in the pharmaceutical industry typically report 'Rest of World' or 'Other' segments to capture revenue from smaller international markets, though the composition of these segments varies significantly based on global footprint.
bmy_segment_other_total_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $191.00M | $276.00M | $221.00M | $227.00M | $192.00M | $215.00M | $200.00M | $155.00M | $175.00M | $185.00M | $184.00M | $199.00M | $176.00M | $271.00M | $350.00M | $218.00M | $270.00M | $290.00M |
| QoQ Change | — | +44.5% | -19.9% | +2.7% | -15.4% | +12.0% | -7.0% | -22.5% | +12.9% | +5.7% | -0.5% | +8.2% | -11.6% | +54.0% | +29.2% | -37.7% | +23.9% | +7.4% |
| YoY Change | — | — | — | — | +0.5% | -22.1% | -9.5% | -31.7% | -8.9% | -14.0% | -8.0% | +28.4% | +0.6% | +46.5% | +90.2% | +9.5% | +53.4% | +7.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.